MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202511122282 A) filed by K. R. Mangalam University, Gurugram, Haryana, on Dec. 5, 2025, for 'nanoparticle-enhanced transdermal patch system for controlled release of antidiabetic therapeutics.'
Inventor(s) include Dr. Pawan Kumar; Dr. Narender Yadav; and Dr. Pratibha Sharma.
The application for the patent was published on Jan. 23, under issue no. 04/2026.
According to the abstract released by the Intellectual Property India: "The invention relates to a nanoparticle-loaded, glucose-responsive transdermal patch for controlled delivery of anti-diabetic drugs. A patch that contains various substances likes a polymer matrix and a glucose-reactive adhesive made on a multilayered structure patch of polymeric drugs. The polymeric drugs are designed as glucose triggerable as well. The glucose-responsive polymer allows a change to occur in glucose levels to swell, giving a way to help control diabetes. This system provides a way for people to control glucose levels that cause hyperglycemic episodes, in a non-invasive and painless way. This is also a way to get people to comply more with diabetes management. The patch is a great system for diabetic management that is also wearable, biodegradable, and self-regulating."
Disclaimer: Curated by HT Syndication.
